Vertex Pharmaceuticals VRTX Fundamental Deep Dive of a HighQuality Biotech Leader With MarketBeating Upside Sensata ST Stock Breakout or Breakdown Sensata posts slight EPS miss Q4 revenue data not available MYRG MYR Group reports large Q1 2026 EPS beat with shares rising modestly in todays trading session GDEV GDEV Q4 2025 EPS falls short of consensus estimates shares drop 756 on investor disappointment NGEN NervGen shares drop 335 percent despite Q3 2025 EPS landing slightly ahead of consensus analyst estimates Is ClearSign CLIR stock considered high volatility Softens 20260427